Assessment of genomic copy number alterations in breast cancer
The aim of this study was to assess genomic copy number alterations in a panel of breast cancer cell lines. These data were used to identify common aberrations associated with breast cancer, and also to identify aberrations associated with response to therapeutic compounds.
- Type: Other
- Archiver: European Genome-Phenome Archive (EGA)
Click on a Dataset ID in the table below to learn more, and to find out who to contact about access to these data
Dataset ID | Description | Technology | Samples |
---|---|---|---|
EGAD00010000490 | Affymetrix 6.0- | 19 |
Publications | Citations |
---|---|
Modeling precision treatment of breast cancer.
Genome Biol 14: 2013 R110 |
182 |
A community effort to assess and improve drug sensitivity prediction algorithms.
Nat Biotechnol 32: 2014 1202-1212 |
372 |
Gene isoforms as expression-based biomarkers predictive of drug response in vitro.
Nat Commun 8: 2017 1126 |
31 |
More than fishing for a cure: The promises and pitfalls of high throughput cancer cell line screens.
Pharmacol Ther 191: 2018 178-189 |
24 |